Dissemin is shutting down on January 1st, 2025

Published in

Springer, Netherlands Heart Journal, S1(28), p. 57-65, 2020

DOI: 10.1007/s12471-020-01445-7

Links

Tools

Export citation

Search in Google Scholar

Coronary computed tomography angiography and [15O]H2O positron emission tomography perfusion imaging for the assessment of coronary artery disease

Journal article published in 2020 by P. A. van Diemen, S. P. Schumacher, R. S. Driessen ORCID, M. J. Bom, W. J. Stuijfzand, H. Everaars ORCID, R. W. de Winter, P. G. Raijmakers, A. C. van Rossum, A. Hirsch, I. Danad, P. Knaapen
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

AbstractDetermining the anatomic severity and extent of coronary artery disease (CAD) by means of coronary computed tomography angiography (CCTA) and its effect on perfusion using myocardial perfusion imaging (MPI) form the pillars of the non-invasive imaging assessment of CAD. This review will 1) focus on CCTA and [15O]H2O positron emission tomography MPI as stand-alone imaging modalities and their combined use for detecting CAD, 2) highlight some of the lessons learned from the PACIFIC trial (Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve (FFR) (NCT01521468)), and 3) discuss the use of [15O]H2O PET MPI in the clinical work-up of patients with a chronic coronary total occlusion (CTO).